Jeffery Kelly

Co-founder; Scripps Research professor

Appears in 1 story

Born: August 23, 1960, Medina

Education: University of North Carolina at Chapel Hill, State University of New York at Fredonia

Last updated Nov 2, 2026

Stories

FDA clears Protego's pivotal trial of PROT-001 for AL amyloidosis

New Capabilities

Scientific founder behind PROT-001

The Food and Drug Administration cleared Protego Biopharma to start SHIELD-AL, a Phase 2/3 trial of PROT-001 in newly diagnosed lambda light chain AL amyloidosis. Protego says the study is planned to begin in the first quarter of 2027.

Updated Oct 25